|
|
||||||||
switches electrophysiological states of synovial
fibroblasts
1 Department of Orthopaedic Surgery and 3 Department of Medicine, Section of Rheumatology, Louisiana State University Medical Center, Shreveport, Louisiana 71130-3932; and 2 Institute of Cell Biophysics, Russian Academy of Sciences, Pushchino, Moscow Region, 142292 Russia
| |
ABSTRACT |
|---|
|
|
|---|
The role of electrophysiological events
in signal transduction of interleukin-1
(IL-1
) was investigated
in rabbit synovial fibroblasts using the perforated-patch method.
Aggregated synovial fibroblasts occurred in two different
electrophysiological states having membrane potentials
(Vm) of
63 ± 4 (n = 71) and
27 ± 10 mV (n = 55) (high and low
Vm,
respectively). IL-1
affected the cells with high
Vm; it switched
the state of the cell from high to low
Vm. This effect
was strongly dependent on the external potential applied to the cell
membrane. Low Vm
(
30 mV) alone without IL-1
did not switch the state
of the cells. Thus a synergistic effect involving the cytokine and cell
Vm in switching
the electrophysiological state of the cell was shown, indicating that
electrophysiological changes are involved in signal transduction. Gap
junctions between aggregated cells were necessary for the cells to have
a high Vm and to
respond to IL-1
. Gap junction resistance between adjacent cells was
estimated as 300 ± 100 M
. Our findings suggest that the
electrophysiological behavior of synovial fibroblasts is tightly connected to a signaling or intracellular mediator system that is
triggered by IL-1
.
cytokine; immunomodulator; patch clamp; membrane potential; arthritis
| |
INTRODUCTION |
|---|
|
|
|---|
CYTOKINES PLAY an important role in cell regulation,
and have been studied intensively in recent years (11, 19). Cytokine interactions with synovial cells can affect their production of matrix
proteases, and abnormal regulation of cytokine-induced pathways is
associated with rheumatoid arthritis and osteoarthritis (2, 30).
Interleukin-1
(IL-1
) is particularly important in this regard
because elevated levels occur in arthritic patients (22, 27), and
IL-1
triggers production of proteases and prostaglandins by synovial
fibroblasts (10, 28) and regulates their synthesis of collagens (4,
14). Despite significant advances in the molecular biology of IL-1
and its receptors and antagonists (1), the immediate posttransduction
pathways are not well understood, particularly with regard to the
possible importance of electrophysiological changes (11, 31, 33).
Our findings show directly a synergistic effect of IL-1
and the
membrane electric potential in switching the electrophysiological state
of HIG-82 cells, a well-studied rabbit synovial cell line (7, 8, 12,
13, 29). Thus the results suggest that the electrophysiological
behavior of the cell must be considered in evaluating the signal
transduction pathway of IL-1
.
| |
METHODS |
|---|
|
|
|---|
Cells. The cells were grown at 37°C, 5% CO2, without antibiotics in 25-ml polystyrene flasks containing F-12 medium (GIBCO BRL) with 10% fetal bovine serum. For passage, confluent cultures were trypsinized (1 ml, 0.08%) for 3-5 min, after which 4 ml of medium was added and the suspended cells were centrifuged, resuspended, and then seeded (106 cells) into 4 ml of medium. For electrophysiological measurements, 105 cells were added to 35-mm petri dishes and incubated at 37°C for 24 h, after which the cells were treated for 2 min with 1 ml of 0.01% collagenase and 0.01% hyaluronidase; this step was necessary to obtain stable gigaseals. The specific consequences of our enzyme treatment, although mild by comparison with routine trypsinization of the cells, have not been conclusively established. The cells were incubated in medium for 40-60 min at 37°C to allow recovery from the enzyme treatment; the medium was then replaced with bath solution, and all measurements were made in bath solution at 25°C, employing the cells (10-20 µm in diameter) that remained adhered to the bottom of the petri dish (most cells remained adherent after enzyme treatment).
The dish containing the clamped cell was rapidly perfused with bath
solution containing human recombinant IL-1
(Sigma no. I-4019) and
0.1% bovine albumin (carrier protein). Control experiments showed that
0.1% bovine albumin did not influence the current-voltage (I-V) characteristic of the cells.
Electrodes. The nystatin
perforated-patch method (17) was used to measure the transmembrane
current at voltage clamp. This method was used because it permits use
of the whole cell configuration for measuring electrical properties of
the cell while preventing diffusion of small signaling molecules from
the cell into the electrode. The nystatin method therefore preserves
intracellular regulation. Glass capillaries 1.0 mm in diameter were
pulled in two steps (PB-7, Narishige) and fire polished in a microforge (MF-9 Narishige). The resistance of the electrodes was 7-9
M
in bath solution. The pipette salt solution was
(in mM) 125 K-aspartate (monopotassium salt), 30 KCl, 4 NaCl, 10 N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES)-KOH, pH 7.2; 318 mosM (calculated). The
composition of the bath solution was (in mM) 145 NaCl, 5.4 KCl, 1.5 CaCl2, 1.0 MgCl2, 5.0 HEPES-NaOH, 5.0 glucose, pH 7.3; 328 mosM (calculated). Because nystatin interfered
with gigaseal formation, the tip of the pipette was filled with a
nystatin-free solution before the addition of pipette solution
containing 0.3 µg/ml of nystatin. The gigaseal was formed during the
time needed for the nystatin to diffuse to the tip of the micropipette
(17).
Measurements. Gigaseals (
10 G
)
were formed under negative pressure (5-10
cmH2O), typically within
0.5-5 min; the success rate was >50%. After gigaseal formation
the negative pressure was removed and the nystatin channels formed
within 5-15 min; the resistance of the perforated-patch membrane
was 40 ± 20 M
. Gigaseals and nystatin pores usually remained
stable for hours.
Membrane potential (Vm; measured as the reversal potential at zero-current clamp), I-V characteristics, and transient currents were recorded using a patch-clamp amplifier (Axopatch 200B, Axon Instruments). The amplifier was connected to a computer (TL-1 DMA Interface, Axon Instruments), and commercial software (pCLAMP 6, Axon Instruments) was used to control the amplifier and to collect and analyze the experimental data. The systematic error of the measurement of Vm due to the electrode potential did not exceed 2 mV. Variation of current and reversal potential at the same conditions was determined by variability of different cells. The error values presented are SE of the mean.
In patients, IL-1
was detected in the marrow plasma at 0.2-0.3
ng/ml and in synovial fluid at 0.15 ng/ml (20, 24). Previous in vitro
studies using HIG-82 cells were typically performed using 0.1-10
ng/ml (18, 34). In the studies reported here, we used 0.1-10
ng/ml, with most studies being performed with 1 ng/ml.
| |
RESULTS |
|---|
|
|
|---|
Vm.
Vm was initially
measured in single HIG-82 cells by the perforated-patch-clamp method
(17), and in most instances a low
Vm was found
immediately after the nystatin channels were formed in the patch
membrane; the mean value was
3 ± 3 mV
(n = 25). Five additional cells
initially exhibited higher values (
37 ± 12 mV,
n = 3, and
63 ± 6 mV,
n = 2), but in each case Vm dropped to
about
3 mV within 15 min.
The results for small cell aggregates (
3 cells) were similar to those
for single cells, but the potentials measured from cells in larger
aggregates were higher and more stable.
Vm measured in
126 cells in aggregates of 5-15 cells (1 measured cell/aggregate) exhibited a bimodal distribution with peaks around
65 mV and
30 mV (Fig. 1). The potentials were
typically stable for >0.5 h. When the distribution was divided at the
point of minimum potential (
45 mV), the means of the two groups
were
63 ± 1 (n = 71) and
27 ± 2 mV (n = 55). Thus
aggregated cells occurred in two different electrophysiological states,
with mean Vm of
63 and
27 mV (high and low
Vm,
respectively).
|
The resistance of the pipette seal was measured in each experiment just
after gigaseal formation and was ~10 G
. The resistance of the
membrane of single cells was ~1 G
, as estimated from their I-V curves. On the basis of Ohm's
law, therefore, the
low-Vm state in
the aggregated cells and the
3-mV state exhibited by single cells were real and were not artifacts due to current leakage through
the pipette seal.
Because Vm
depends on position in the cell cycle (6, 21, 32), it was possible that
the distribution of
Vm resulted from
sampling of cells in different positions in the cycle. To explore this
possibility, cells were prepared as they would have been for
electrophysiological study, but instead were used to evaluate the
distribution of the cells in the cycle. After the collagenase-hyaluronidase treatment of a sufficiently large number of
petri dishes, the adhering cells were trypsinized, permeabilized, reacted with propidum iodide, and then analyzed by flow cytometry to
assess DNA content (25). On the basis of cellular DNA analysis by flow
cytometry, 81% of the cells were in
G0/G1,
9% in S-phase, and 10% in the
G2+M phase. With
45 mV as
the dividing line, the cell states were in a proportion of 56 to 44%
(Fig. 1), which did not correlate with the results of the cell cycle
analysis showing that 81% of the cells were in
G0/G1.
Gap
junction
resistance. The necessity of cell
aggregation for
high-Vm
measurements (Vm <
45 mV) led us to consider whether aggregated cells were in
electrochemical communication, and we therefore developed a method to
investigate the possibility of gap junctions. After formation of a
perforated patch, a 2-mV step was applied and the transient current
passing through the electrode was measured in aggregates of different
sizes. Analysis (see APPENDIX) showed that the time constant of the transient current decay depended strongly on the resistance between adjacent cells in an aggregate. If
cells in an aggregate were electrically separated from each other, the
resistance would be high and the time constant would be low regardless
of the number of cells in the aggregate, because the voltage step would
charge the membrane capacitance of only one cell. However, if the cells
were connected to each other by gap junctions, the resistance would be
relatively low and the time constant of the current decay would be
greater with an increasing number of cells in the aggregate because the
voltage step would charge the membrane capacitance of all cells in the
aggregate.
The time constant for a typical cell in a large aggregate was more than
three orders of magnitude greater in comparison with that from a single
cell (Fig. 2,
curves
1 and
4), leading to the conclusion that
the aggregated synovial fibroblasts were connected to each other by gap
junctions. The gap junction resistance between adjacent cells was found
by the method described in the
APPENDIX to be 300 ± 100 M
in
measurements for seven different aggregates of two or three cells.
|
Gap junction resistance was not ascertained for larger aggregates because the calculations would have required specification of the two-dimensional geometry of the aggregate. Large aggregates can have many different geometries, so there was little practical reason to extend the calculation to large aggregates.
The assumption that gap junction resistance (r) is constant for all pairs of adjacent cells (Fig. 2) in an aggregate of given size is supported by the observation that elementary gap junctions can be disassembled into half pores that can laterally diffuse in the membrane and assemble into new elementary gap junctions with other cells having half pores (23). This suggests that the equilibrium distribution of elementary gap junctions between all pairs of cells in an aggregate is uniform (under the assumption that the total number of half pores for each cell is equal) and thus that r is constant for all pairs of adjacent cells in the aggregate.
Effect of IL-1
. Cells
displaying a high
Vm were exposed
to IL-1
(0.1-10 ng/ml; most experiments were done at 1 ng/ml)
and the time dependence of the Vm
was observed. Application of IL-1
did not produce a
consistent effect on
Vm; 19 of 27 cells did not respond to the addition of 1 ng/ml IL-1
, but eight
cells showed a decrease to
30 ± 12 mV within 30-40 min.
Experimental records for three of these cells are shown in Fig.
3. When the effect of IL-1
on
Vm occurred (Fig.
3) it was reversible, but only when interrupted before completion of
the depolarization process (by removal of the IL-1
from the bath
solution). Reversibility was confirmed for five different cells.
|
Cells with a low
Vm
(Vm >
45
mV) did not respond to the presence of IL-1
. The last result was
confirmed in measurements from five different cells in which the cell
was initially exposed to 0.1 ng/ml for 15 min and then to 1 and 10 ng/ml (for 15 min in each case).
In an attempt to understand why only some cells responded to IL-1
,
we tried to maximize the effect. It was suggested that the
intracellular signaling cascade triggered by the interaction of IL-1
with its receptor may involve influx of
Ca2+ (3, 11, 31). Because some
Ca2+ channels are voltage
sensitive and have a high probability of being open at membrane
voltages such that
Vm
30
mV (9, 15), we hypothesized that the probability for IL-1
to cause
particular cells to transition from high to low
Vm would be
enhanced if voltage-gated Ca2+
channels were opened simultaneously with those linked to the IL-1
receptors. We therefore measured the IL-1
effect on cells under
30-mV voltage clamp.
A typical I-V curve from a cell in the
high-Vm state is
shown in Fig. 4. The cell exhibited a
Vm of about
70 mV and a region of negative slope commencing around
30
mV. The effect of IL-1
on the I-V
curve of a
high-Vm cell is
shown in Fig. 5. After the initial
measurement (Fig. 5A,
curve
1) the cell was held at
30 mV
for 15 min to promote entry of
Ca2+ before the addition of
IL-1
. A change in the I-V curves
was seen, but the cell did not transition to the
low-Vm state
(Fig. 5A,
curve
2). When 1 ng/ml IL-1
was added
to the bath solution, the I-V curve
changed significantly within 3-5 min and the
Vm shifted from
63 mV to about
40 mV (Fig.
5B). As shown in Fig. 5, addition of
IL-1
caused an increase in inward current. When the IL-1
was
removed and the cell was held at
70 mV (to permit the
voltage-gated Ca2+ channels to
return to their resting condition), the cell substantially returned to
its initial condition (Fig. 5C).
I-V curves of one cell at different
IL-1
concentrations are presented in Fig. 5 as continuous lines.
Mean values (±SE) of the current for five different cells are also
shown in Fig. 5.
|
|
IL-1
had no discernible effect on the
I-V characteristic of cells with low
Vm (Fig.
6) (5 cells were measured at 1 ng/ml and 2 cells at 10 ng/ml).
|
| |
DISCUSSION |
|---|
|
|
|---|
Addition of IL-1
produced a rapid (5-15 min) depolarization
only in cells having a high
Vm. IL-1
switched the electrophysiological state of the cell from the high- to
the low-Vm state.
This effect was strongly dependent on the
Vm applied to the
cell membrane from an external source. If IL-1
was added at
zero-current clamp mode (meaning that the average initial
Vm was about
63 mV), most of the cells
(70%) did not exhibit a change to the state with low potential. But if
the cells with high
Vm were clamped
at a low potential (
30 mV), then 100% of cells exhibited a
change to the state with low potential after addition of IL-1
. Low
Vm (
30 mV)
alone without IL-1
did not cause the cells to switch from the high-
to the low-Vm
state. These observations indicated a synergistic effect of IL-1
and
membrane electric potential in the cells. Thus the electrophysiological
behavior of the cell must be considered in evaluating the signal
transduction pathway of IL-1
. The perforated patch-clamp method is
ideal for studying electrophysiological effects connected with
second-messenger systems because this method permits use of the whole
cell configuration for measuring electrical properties of the cell and
does not permit small signaling molecules to diffuse into the
electrode.
The preparation of IL-1
had a purity >97% and it produced the
effects at 1 ng/ml. Therefore we can assume with high probability that
the observed effects were caused by IL-1
itself. Nevertheless, we
cannot exclude the possibility that an unknown substance in the IL-1
preparation produced the observed effects at <0.03 ng/ml.
We found that gap junctions between aggregated synovial cells were
necessary to have the high
Vm to permit the
cells to respond to IL-1
. Gap junctions have been reported in normal
human synovium, and they appear to occur more frequently in
osteoarthritis (26).
Because the synovial cells were connected by gap junctions, it is
possible that the consequences of a ligand-receptor interaction in one
or a few cells in an aggregate could spread either actively or
passively through an ensemble of cells, effectively propagating the
ability of cells to transition from the high- to the
low-Vm state (5,
16). If such a mechanism operated in vivo, it would permit a response
by large regions of the synovium (in either normal or pathological
cases) after ligand-receptor interactions in localized regions. The
effective IL-1
concentrations in these studies (1 ng/ml) were
reasonably comparable to levels measured in patients (20, 24), and gap
junctions have been described in synovial tissue (26). This evidence
suggests, therefore, that the observations reported here are relevant
to the clinical situation.
Our findings suggest that the electrophysiological behavior of synovial
fibroblasts is tightly connected to a signaling or intracellular
mediator system that is modulated by IL-1
.
Perspectives
Attempts to understand the pathophysiological mechanisms of arthritis usually focus on identifying chemical pathways that link cytokine signals with protein synthesis. Our studies suggest that electrophysiological changes may occur early in the signal detection process before any changes in gene transcription or protein synthesis. Thus the mechanisms that mediate the electrical changes are potential targets for rational therapy aimed at altering the subsequent signal transduction cascade. Furthermore, our observation that the synovial fibroblasts formed gap junctions raises the possibility that electrical coupling between the synoviocytes might be an important aspect of synovial physiology. If functional gap junctions are observed in cultures of human synovial fibroblasts and in human synovial tissue, then studies of the properties of such gap junctions might lead to significant advances in understanding both normal and abnormal synovial tissue. For example, on the basis of morphological evidence, it appears that the number of synovial gap junctions is altered in arthritic patients (26). Thus it is possible that changes in gap junctions might play a causative role in development of arthritis.| |
APPENDIX. TRANSIENT CURRENT FOR AN AGGREGATE OF CELLS CONNECTED TO EACH OTHER BY GAP JUNCTIONS |
|---|
|
|
|---|
Assume that the measured cell in an aggregate is surrounded by n identical adjacent cells and that gap junctions are present between adjacent cells. If a voltage step (V) is applied to the electrode, the resulting current (I) satisfies
|
|
|
|
|
|
.
For the case of a single cell (n = 0, r
), k1 = k2 = 1/RC.
R was found from the initial
condition, R = V/I(0),
where V = 2 mV; C was obtained by
fitting the solution
{I(t) = I(0)
exp[
t/RC]} to the experimental curve (Fig. 2,
curve
1). The result was C = 3.47 pF.
Measurements were made on cells that were oblate ellipsoids having
major and minor axes of 12 ± 1 and 6 ± 1 µm,
respectively. On the assumption that the plasma membrane capacity was 1 µF/cm2, it can be shown that C = 3.2 ± 0.6 pF, in good agreement with the results obtained by curve
fitting.
Employing the value of C ascertained from measurements on single cells, gap junction resistance (r) was estimated by fitting the theoretical solution for I(t) to experimental curves 2 and 3 in Fig. 2 (which correspond to n = 1 and n = 2, respectively). Fitting was done by the method of least squares, with fractional error of 0.001.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by Louisiana State University Medical Center, Center for Excellence in Arthritis and Rheumatology.
| |
FOOTNOTES |
|---|
Address for reprint requests: A. A. Marino, Dept. of Orthopaedic Surgery, LSUMC, PO Box 33932, Shreveport, LA 71130-3932.
Received 29 May 1997; accepted in final form 7 August 1997.
| |
REFERENCES |
|---|
|
|
|---|
1.
Arend, W. P.
Interleukin-1 receptor antagonist.
Adv. Immunol.
54:
167-227,
1993[Medline].
2.
Arend, W. P.,
and
J. M. Dayer.
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.
Arthritis Rheum.
33:
305-315,
1990[Medline].
3.
Baratz, M. E.,
H. I. Georgescu,
and
C. H. Evans.
Studies on the autocrine activation of a synovial cell line.
J. Orthop. Res.
9:
651-657,
1991[Medline].
4.
Bathon, J. M.,
J. J. Hwang,
L. H. Shin,
P. A. Precht,
M. C. Towns,
and
J. Horton.
Type VI collagen-specific messenger RNA is expressed constitutively by cultured human synovial fibroblasts and is suppressed by interleukin-1.
Arthritis Rheum.
37:
1350-1356,
1994[Medline].
5.
Boitano, S.,
E. R. Dirksen,
and
M. J. Sanderson.
Intercellular propagation of calcium waves mediated by inositol triphosphate.
Science
258:
292-295,
1992
6.
Boonstra, J.,
C. L. Mummery,
L. G. Tertoolen,
P. T. van der Saag,
and
S. W. de Laat.
Cation transport and growth regulation in neuroblastoma cells. Modulations of K+ transport and electrical membrane properties during the cell cycle.
J. Cell. Physiol.
107:
75-83,
1981[Medline].
7.
Brinckerhoff, C. E.,
R. H. Gross,
H. Nagase,
L. Sheldon,
R. C. Jackson,
and
E. D. Harris.
Increased level of translatable collagenase messenger ribonucleic acid in rabbit synovial fibroblasts treated with phorbol myristate acetate or crystals of monosodium urate monohydrate.
Biochemistry
21:
2674-2679,
1982[Medline].
8.
Brinckerhoff, C. E.,
and
T. I. Mitchell.
Autocrine control of collagenase synthesis by synovial fibroblasts.
J. Cell. Physiol.
136:
72-80,
1988[Medline].
9.
Cena, V.,
K. W. Brocklehurst,
H. B. Pollard,
and
E. Rojas.
Pertussis toxin stimulation of catecholamine release from adrenal medullary chromaffin cells: mechanism may be direct activation of L-type and G-type calcium channels.
J. Membr. Biol.
122:
23-31,
1991[Medline].
10.
Dayer, J. M.,
S. M. Krane,
R. G. Russell,
and
D. R. Robinson.
Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells.
Proc. Natl. Acad. Sci. USA
73:
945-949,
1976
11.
Dinarello, C. A.
The interleukin-1 family: 10 years of discovery.
FASEB J.
8:
1314-1325,
1994[Abstract].
12.
Evans, C. H.,
D. C. Mears,
and
J. L. Cosgrove.
Release of neutral proteases from mononuclear phagocytes and synovial cells in response to cartillagenous wear particles.
Biochim. Biophys. Acta
667:
287-294,
1981.
13.
Georgescu, H. I.,
D. Mendelow,
and
C. H. Evans.
HIG-82: an established cell line from rabbit periarticular soft tissue, which retains the "activatable" phenotype.
In Vitro (Rockville)
24:
1015-1022,
1988.
14.
Goldring, M. B.,
and
S. M. Krane.
Modulation by recombinant interleukin 1 of synthesis of types I and III collagens and associated procollagen mRNA levels in cultured human cells.
J. Biol. Chem.
262:
16724-16729,
1987
15.
Guggino, S. E.,
D. Lajeunesse,
J. Wagner,
and
S. Snyder.
Bone remodeling signaled by a dihydropyridine- and phenylalkylamine-sensitive calcium channel.
Proc. Natl. Acad. Sci. USA
86:
2957-2960,
1989
16.
Hansen, M.,
S. Boitano,
E. R. Dirksen,
and
M. J. Sanderson.
A role for phospholipase C activity but not ryanodine receptors in the initiation and propagation of intercellular calcium waves.
J. Cell Sci.
108:
2583-2590,
1995[Abstract].
17.
Horn, R.,
and
A. Marty.
Muscarinic activation of ionic currents measured by a new whole-cell recording method.
J. Gen. Physiol.
92:
145-159,
1988
18.
Hulkower, K.
Interleukin-1 and synovial protein kinase C: identification of a novel, 35 kDa cytosolic substrate.
Agents Actions
34:
278-281,
1991[Medline].
19.
Ivashkiv, L. B.
Cytokine expression and cell activation in inflammatory arthritis.
Adv. Immunol.
63:
337-376,
1996[Medline].
20.
Kassem, M.,
S. Khosla,
and
B. L. Riggs.
No evidence in early postmenopausal women for estrogen regulation of cytokine production: assessment in bone marrow plasma in vivo and in cultured bone marrow cells.
In: Am. Soc. Bone and Mineral Res. 1995 Annual Mtg, 1995.
21.
Kiefer, H.,
A. J. Blume,
and
H. Kaback.
Membrane potential changes during mitotic stimulation of mouse spleen lymphocytes.
Proc. Natl. Acad. Sci. USA
77:
2200-2204,
1980
22.
Kirkham, B.
Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis.
Ann. Rheum. Dis.
50:
395-400,
1991
23.
Kleinsmith, L.,
and
V. Kish.
Principles of Cell and Molecular Biology. New York: Harper Collins, 1995.
24.
Madson, K. L.,
T. L. Moore,
J. M. Lawrence III,
and
T. G. Osborn.
Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis.
J. Rheumatol.
21:
2359-2363,
1994[Medline].
25.
McCarthy, R. C.,
and
T. J. Fetterhoff.
Issues for quality assurance in clinical flow cytometry.
Arch. Pathol. Lab. Med.
113:
658-666,
1989[Medline].
26.
Meek, W. D.,
B. T. Raber,
O. M. McClain,
J. K. McCosh,
and
B. B. Baker.
Fine structure of the human synovial lining cell in osteoarthritis: its prominent cytoskeleton.
Anat. Rec.
231:
145-155,
1991[Medline].
27.
Miossec, P.,
C. A. Dinarello,
and
M. Ziff.
Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid.
Arthritis Rheum.
29:
461-470,
1986[Medline].
28.
Okada, Y.,
H. Nagase,
and
J. Harris.
A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components: purification and characterization.
J. Biol. Chem.
261:
14245-14255,
1986
29.
Okazai, I.,
C. E. Brinckerhoff,
J. F. Sinclair,
P. R. Sinclair,
H. L. Burkowski,
and
E. D. Harris.
Iron increases collagenase production by rabbit synovial fibroblasts.
J. Lab. Clin. Med.
97:
396-402,
1981[Medline].
30.
Pelletier, J.-P.,
J. A. DiBattista,
P. Roughley,
R. McCollum,
and
J. Martel-Pelletier.
Cytokines and inflammation in cartilage degradation.
Rheum. Dis. Clin. North Am.
19:
545-569,
1993[Medline].
31.
Rossi, B.
IL-1 transduction signals.
Cytokine Netw.
4:
181-187,
1993[Medline].
32.
Sachs, H. G.,
P. J. Stambrook,
and
J. D. Ebert.
Changes in membrane potential during the cell cycle.
Exp. Cell Res.
83:
362-366,
1974[Medline].
33.
Saklatvala, J.
Intracellular signaling mechanisms of interleukin 1 and tumor necrosis factor: possible targets for therapy.
Br. Med. Bull.
51:
402-418,
1995
34.
Stefanovic-Racic, M.,
J. Stadler,
H. I. Georgescu,
and
C. H. Evans.
Nitric oxide synthesis and its regulation by rabbit synoviocytes.
J. Rheumatol.
21:
1892-1898,
1994[Medline].
This article has been cited by other articles:
![]() |
O. V. Kolomytkin, A. A. Marino, K. K. Sadasivan, R. E. Wolf, and J. A. Albright Intracellular signaling mechanisms of interleukin-1beta in synovial fibroblasts Am J Physiol Cell Physiol, January 1, 1999; 276(1): C9 - C15. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. V. Kolomytkin, A. A. Marino, D. D. Waddell, J. M. Mathis, R. E. Wolf, K. K. Sadasivan, and J. A. Albright IL-1beta -induced production of metalloproteinases by synovial cells depends on gap junction conductance Am J Physiol Cell Physiol, June 1, 2002; 282(6): C1254 - C1260. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |